Health
Medicine to prevent patients from developing COVID-19 tested in UK – TASS
Scientists hope that people wouls be protected from COVID-19 for a period of between six months and one year
LONDON, December 26. /TASS/. A medicine that can potentially prevent people exposed to novel coronavirus from developing COVID-19 is now being tested in the United Kingdom, the Guardian reported on its website Friday.
The medicine, based on monoclonal antibodies created in a laboratory, was developed by UK-Swedish pharmaceutical company AstraZeneca and the University College London Hospitals.
“If we can prove that this treatment works and prevent people who are exposed to the virus going on to develop…
-
Business21 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General21 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
General21 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts
-
General17 hours agoUS authorities to set targets to lower medicine prices